Product NDC: | 63739-458 |
Proprietary Name: | Atropine Sulfate |
Non Proprietary Name: | Atropine Sulfate |
Active Ingredient(s): | .1 mg/mL & nbsp; Atropine Sulfate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63739-458 |
Labeler Name: | McKesson Packaging Services Business Unit of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021146 |
Marketing Category: | NDA |
Start Marketing Date: | 20100503 |
Package NDC: | 63739-458-05 |
Package Description: | 5 POUCH in 1 BOX (63739-458-05) > 1 BOX in 1 POUCH (63739-458-21) > 1 SYRINGE, GLASS in 1 BOX > 10 mL in 1 SYRINGE, GLASS |
NDC Code | 63739-458-05 |
Proprietary Name | Atropine Sulfate |
Package Description | 5 POUCH in 1 BOX (63739-458-05) > 1 BOX in 1 POUCH (63739-458-21) > 1 SYRINGE, GLASS in 1 BOX > 10 mL in 1 SYRINGE, GLASS |
Product NDC | 63739-458 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Atropine Sulfate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20100503 |
Marketing Category Name | NDA |
Labeler Name | McKesson Packaging Services Business Unit of McKesson Corporation |
Substance Name | ATROPINE |
Strength Number | .1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |